Serveur d'exploration sur les relations entre la France et l'Australie

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Eléments de l'association

Stephen Macmahon21
Homme1515
Stephen Macmahon Sauf Homme" 10
Homme Sauf Stephen Macmahon" 1504
Stephen Macmahon Et Homme 11
Stephen Macmahon Ou Homme 1525
Corpus11069
\n\n\n\n \n

List of bibliographic references

Number of relevant bibliographic references: 11.
Ident.Authors (with country if any)Title
000A91 Pamela M. Rist [États-Unis] ; John Chalmers [Australie] ; Hisatomi Arima [Australie] ; Craig Anderson [Australie] ; Stephen Macmahon [Australie] ; Mark Woodward [Australie] ; Tobias Kurth [États-Unis, France] ; Christophe Tzourio [France]Baseline Cognitive Function, Recurrent Stroke, and Risk of Dementia in Patients With Stroke
001179 Hisatomi Arima [Australie] ; Craig Anderson [Australie] ; Teruo Omae [Japon] ; Mark Woodward [Australie] ; Stephen Macmahon [Australie, Royaume-Uni] ; Giuseppe Mancia [Italie] ; Marie-Germaine Bousser [France] ; Christophe Tzourio [France] ; Anthony Rodgers [Australie] ; Bruce Neal [Australie] ; John Chalmers [Australie]Effects of Blood Pressure Lowering on Intracranial and Extracranial Bleeding in Patients on Antithrombotic Therapy: The PROGRESS Trial
001E05 Jasper J. Brugts [Pays-Bas] ; Aaron Isaacs [Pays-Bas] ; Moniek P. M. De Maat [Pays-Bas] ; Eric Boersma [Pays-Bas] ; Cock M. Van Duijn [Pays-Bas] ; K. Martijn Akkerhuis [Pays-Bas] ; Andre G. Uitterlinden [Pays-Bas] ; Jacqueline C. M. Witteman [Pays-Bas] ; Francois Cambien [France] ; Claudio Ceconi [Italie] ; Willem Remme [Pays-Bas] ; Michel Bertrand [France] ; Toshiharu Ninomiya [Australie] ; Stephen Harrap [Australie] ; John Chalmers [Australie] ; Stephen Macmahon [Australie] ; Kim Fox [Royaume-Uni] ; Roberto Ferrari [Italie] ; Maarten L. Simoons [Pays-Bas] ; A. H. Jan Danser [Pays-Bas]A pharmacogenetic analysis of determinants of hypertension and blood pressure response to angiotensin-converting enzyme inhibitor therapy in patients with vascular disease and healthy individuals
002389 Jasper Jan Brugts [Pays-Bas] ; Aaron Isaacs [Pays-Bas] ; Eric Boersma [Pays-Bas] ; Cock M. Van Duijn [Pays-Bas] ; Andre G. Uitterlinden [Pays-Bas] ; Willem Remme [Pays-Bas] ; Michel Bertrand [France] ; Toshiharu Ninomiya [Australie] ; Claudio Ceconi [Italie] ; John Chalmers [Australie] ; Stephen Macmahon [Australie] ; Kim Fox [Royaume-Uni] ; Roberto Ferrari [Italie] ; Jacqueline C. M. Witteman [Pays-Bas] ; A. H. Jan Danser [Pays-Bas] ; Maarten L. Simoons [Pays-Bas] ; Moniek P. M. De Maat [Pays-Bas]Genetic determinants of treatment benefit of the angiotensin-converting enzyme-inhibitor perindopril in patients with stable coronary artery disease
002768 Jasper J. Brugts [Pays-Bas] ; Toshiharu Ninomiya [Australie] ; Eric Boersma [Pays-Bas] ; Willem J. Remme [Pays-Bas] ; Michel Bertrand [France] ; Roberto Ferrari [Italie] ; Kim Fox [Royaume-Uni] ; Stephen Macmahon [Australie] ; John Chalmers [Australie] ; Maarten L. Simoons [Pays-Bas]The consistency of the treatment effect of an ACE-inhibitor based treatment regimen in patients with vascular disease or high risk of vascular disease: a combined analysis of individual data of ADVANCE, EUROPA, and PROGRESS trials
002856 Carole Dufouil [France] ; Ophélia Godin [France] ; John Chalmers [Australie] ; Oghuzan Coskun [France] ; Stephen Macmahon [Australie] ; Nathalie Tzourio-Mazoyer [France] ; Marie-Germaine Bousser [France] ; Craig Anderson [Australie] ; Bernard Mazoyer [France] ; Christophe Tzourio [France]Severe Cerebral White Matter Hyperintensities Predict Severe Cognitive Decline in Patients With Cerebrovascular Disease History
002C37 Sophia Zoungas [Australie] ; Bastiaan E. De Galan [Australie, Pays-Bas] ; Toshiharu Ninomiya [Australie] ; Diederick Grobbee [Pays-Bas] ; Pavel Hamet [Canada] ; Simon Heller [Royaume-Uni] ; Stephen Macmahon [Australie] ; Michel Marre [France] ; Bruce Neal [Australie] ; Anushka Patel [Australie] ; Mark Woodward [Australie, États-Unis] ; John Chalmers [Australie]Combined Effects of Routine Blood Pressure Lowering and Intensive Glucose Control on Macrovascular and Microvascular Outcomes in Patients With Type 2 Diabetes: New results from the ADVANCE trial
004446 Pierre Amarenco [France] ; Anushka Patel [France] ; Mark Woodward [France] ; Duncan J. Campbell [Australie] ; David R. Sullivan [Australie] ; Samuel Colman [France] ; John Chalmers [France] ; Bruce Neal [France] ; Stephen Macmahon [France]Plasma lipids predict myocardial infarction, but not stroke, in patients with established cerebrovascular disease
004640 Carole Dufouil [France] ; John Chalmers [Australie] ; Oguzhan Coskun [France] ; Véronique Besancon [France] ; Marie-Germaine Bousser [France] ; Pierre Guillon [France] ; Stephen Macmahon [Australie] ; Bernard Mazoyer [France] ; Bruce Neal [Australie] ; Mark Woodward [Australie] ; Nathalie Tzourio-Mazoyer [France] ; Christophe Tzourio [France, Australie]Effects of blood pressure lowering on cerebral white matter hyperintensities in patients with stroke : The PROGRESS (Perindopril Protection Against Recurrent Stroke Study) magnetic resonance imaging substudy
004A11 Anthony Rodgers [Nouvelle-Zélande] ; Neil Chapman [Australie] ; Mark Woodward [Australie] ; Li-Sheng Liu [République populaire de Chine] ; Sam Colman [Australie] ; Arier Lee [Nouvelle-Zélande] ; John Chalmers [Australie] ; Stephen Macmahon [Australie] ; Francois Gueyffier [France]Perindopril-based blood pressure lowering in individuals with cerebrovascular disease: consistency of benefits by age, sex and region. Commentary
004D83 Stephen B. Harrap [Australie] ; Christophe Tzourio [France] ; Francois Cambien [France] ; Odette Poirier [France] ; Segolene Raoux [France] ; John Chalmers [Australie] ; Neil Chapman [Australie] ; Samuel Colman [Australie] ; Solenn Leguennec [France] ; Stephen Macmahon [Australie] ; Bruce Neal [Australie] ; Takayoshi Ohkubo [Australie] ; Mark Woodward [Australie]The ACE gene I/D polymorphism is not associated with the blood pressure and cardiovascular benefits of ACE inhibition

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024